Wird geladen...

Neoadjuvant treatment for resectable pancreatic adenocarcinoma

Pancreatic adenocarcinoma is the fourth leading cause of cancer mortality in the United States in both men and women, with a 5-year survival rate of less than 5%. Surgical resection remains the only curative treatment, but most patients develop systemic recurrence within 2 years of surgery. Adjuvant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Clin Oncol
Hauptverfasser: Wong, John, Solomon, Naveenraj L, Hsueh, Chung-Tsen
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Inc 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734931/
https://ncbi.nlm.nih.gov/pubmed/26862486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v7.i1.1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!